Dexamethasone in childhood ALL and bone health
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how the body processes a steroid medicine called dexamethasone in children with ALL, and how it might affect bone strength.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have acute lymphoblastic leukemia (ALL), a type of blood cancer.
- Your child should be between 1 and 17 years old.
- Children with Down syndrome cannot take part in this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers key health information at the start of treatment for children and teens newly diagnosed with certain types of leukemia or lymphoma. The goal is to find the best way to begin therapy right away, without waiting for extra tests.
This trial tests a standard chemotherapy regimen for people aged 18 to 50 with a type of leukemia called Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). It aims to see how well the treatment works for this age group.
This trial tests an experimental drug called asciminib for children and young adults whose leukemia (a specific type of B-cell acute lymphoblastic leukemia with certain gene changes) has come back or not responded to treatment. The goal is to see if the drug is safe and effective for these patients.
This Phase 1/2 trial tests a combination of medicines (dasatinib, venetoclax, dexamethasone, cyclophosphamide, and cytarabine) in children and teens whose blood cancer has come back or did not respond to treatment. It aims to see whether this approach can control the cancer while checking what doses are safe.
This study looks at how blood sugar changes in children and teens receiving treatment for ALL (a leukemia) or lymphoma. It focuses specifically on effects that may be caused by steroids and a medicine called PEG-asparaginase.
This study looks at how the adrenal glands recover after children with leukemia or lymphoma are treated with steroids. The goal is to see how common adrenal suppression is and to help doctors monitor this safely.
Hear when a new Acute Lymphoblastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.